COO as of Oct 31 · 20:01 ET
COONasdaqOphthalmic Goods
Cooper Companies, Inc. · Brief
Next report
32 days
Dec 3 · after closeest.Q4 FY26
Expected move
Inputs5 of 8≥ implied
- avg implied
- ±7.9%
- avg realized
- ±9.0%
Dec 5 '24±6.5%▼−4.39%×0.68
Mar 6 '25±6.4%▼−6.57%×1.02
May 29 '25±7.5%▼−14.61%×1.95
Aug 27 '25±7.7%▼−12.85%×1.67
Dec 4 '25±9.0%▲+5.67%×0.63
Q1 FY26±8.3%▼−4.55%×0.55
Q2 FY26±8.4%▲+8.58%×1.02
Q3 FY26±9.6%▼−14.67%×1.53
quarterimplied−15%0+15%realized×
Q3 FY26±9.6%▼−14.67%×1.53
Q2 FY26±8.4%▲+8.58%×1.02
Q1 FY26±8.3%▼−4.55%×0.55
Dec '25±9.0%▲+5.67%×0.63
Aug '25±7.7%▼−12.85%×1.67
May '25±7.5%▼−14.61%×1.95
2 older reports
Mar '25±6.4%▼−6.57%×1.02
Dec '24±6.5%▼−4.39%×0.68
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close
Bull & bear
Dec 3 report · est.Bull2
Bear2 of 3
−4.25%change in shares held by the largest reporting managers over the latest quarter13F · Jun 30 '26
AI captions · Sep 28 '26once per report · top 2 per case
Linked exposure
COO report sessionCustomers 1
× = co-movement · max 500dSource: SEC filings · market data
No changes.
Your note
privateThesis 0 · Decisions 0 · Observations 0
No thesis.